EOS imaging Announces First System Installation within Asklepios Private Hospital Group in Germany
February 21 2018 - 12:00PM
Business Wire
The second largest private hospital group in
Germany adopts EOS® for its Asklepios Paulinen Hospital
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI -
Eligible PEA - PME), the pioneer of 2D/3D imaging and data
solutions for orthopedics, today announced the first installation
of an EOS® system within the Asklepios Hospital Group, the second
largest private hospital network in Germany. The EOS system is
available at the Asklepios Paulinen Hospital, enabling 3D full-body
imaging at a low-dose of radiation, and reinforcing the hospital’s
mission as a “Center of Excellence” for back disorders and
treatment. The Asklepios Paulinen Hospital hosted a ceremony to
celebrate the installation and introduce the community to the EOS
system on February 21, 3:00 – 5:00 pm CET.
The Asklepios Paulinen Hospital is a general hospital with 316
beds located in Wiesbaden, Germany that specializes in
state-of-the-art methods for improved patient care. In order to
diagnose and treat patients in an interdisciplinary manner, it
established several specialized medical centers including spinal
surgery and orthopedics. With the installation of the EOS system,
the spine and orthopedic team has taken another step towards an
integrative "Center of Excellence" for the diagnosis and treatment
of back disorders. The new device represents a major advance in
diagnostics, the subsequent treatment planning and the treatment
control of malpositions and deformities of the musculoskeletal
system.
“I am thrilled with the new system, which opens up a whole new
range of diagnostic options, including more than 100 3D clinical
parameters that provide information on the spine's angular and
axial relationships with unprecedented precision. Particularly for
patients with deformities like scoliosis, the Micro Dose option is
a clear advantage, allowing us to take pictures with minimal
radiation while maintaining excellent image quality," commented
Professor Dr. Thomas Niemeyer, Head of the Spine Surgery
Department.
“We are pleased to expand our presence in Germany with this
installation," commented Marie Meynadier, Chief Executive Officer
of EOS imaging. “The Asklepios Hospital Group is committed to
advancing the orthopedic standard of care, as evidenced by building
a Center of Excellence for the diagnosis and treatment of back
disorders at the Asklepios Paulinen Hospital. We look forward to
our technology contributing to this commitment.”
About EOS imaging
EOS imaging designs, develops, and markets EOS®, an innovative
medical imaging system dedicated to osteoarticular pathologies and
orthopaedics, as well as associated solutions. The Company is
authorized to market in 51 countries, including the United States
(FDA), Japan and the European Union (EC). The Group posted 2017
sales of €37.1 million and employs 152 people at December 2017. The
Group is based in Paris and has five subsidiaries in Besançon
(France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt
(Germany) and Singapore.
EOS imaging has been selected to integrate the EnterNext ©
PEA - PME 150 index, composed of 150 French, listed companies on
the Euronext markets in Paris.
EOS imaging is listed on Compartment C of Euronext ParisISIN:
FR0011191766 - Ticker: EOSI
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180221005915/en/
EOS imagingPierre Schwich, +33 (0)1 55 25 61
24CFOinvestors@eos-imaging.comorThe Ruth Group (US)Press
relationsJoanna Zimmerman,
646-536-7006jzimmerman@theruthgroup.com